Oil Price Reversal Highlights Geopolitical Risk as Key Driver for Crude Markets What 4500 Monthly Retirement Income Looks Like at Age 62 Cautiously Optimistic on India as Earnings Revival Takes Center Stage Says Arvind Sanger London Stock Exchange Group Reports Income Growth Driven by Tradeweb Performance CPF LIFE vs SelfInvestment The Retirement Decision Hinges on Financial Management in Old Age Barclays Reports 18 Profit Rise Raises Income Guidance Amid Strong Performance Runway Growth Finance Corp 725 Notes due 2031 RWAYI Q1 2026 Earnings EPS Misses Estimates Amid Higher Provisioning First Citizens BancShares FCNCA Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Uptick Guardian Pharmacy Services Q1 2026 Earnings EPS Miss Drags but Stock Holds Steady GRWG Q1 2026 Earnings Narrow EPS Beat Highlights Cost Discipline Amidst Market Challenges LivaNova LIVN Q1 2026 Earnings EPS Beats Estimates by 714 Amid Modest Stock Decline OXSQG Q1 2026 Earnings EPS Misses Estimates as Investment Income Falls Short Note Price Holds Steady ZK International Group ZKIN Shares Slide 7 as Resistance Holds Firm SouthState Bank SSB Holds Steady After Slight Uptick Testing Key Resistance Ocular Therapeutix OCUL Rises 3 as Investor Sentiment Strengthens Western Asset Managed Municipals Fund MMU Holds Near Support Amid Modest Decline Victorias Secret Co VSCO Strengthens as Retail Sector Sentiment Shifts GitHub Outages Threaten Microsofts AI Coding Edge as Competition Surges LXFR Q1 2026 Earnings EPS Surges Past Estimates with 32 Beat Crescent Biopharma CBIO Surges 459 as Biotech Sector Gains Momentum Pimco Corporate Income Strategy Fund PCN Holds Steady Near 1170 as Yield Attracts Income Seekers Piper Sandler PIPR Declines 101 as Stock Hovers Near Support Testing Recent Lows Blackrock MuniHoldings New Jersey Quality Fund MUJ Edges Higher as TaxFree Income Draws Steady Demand Addex Therapeutics ADXN Holds Gains Amid Biotech Sector Momentum Fortive FTV Edges Lower Amid Market Caution Testing Key Support Levels Norwegian Cruise Line NCLH Struggles Near Support After Marginal Decline Silexion Therapeutics Corp Warrant SLXNW Faces Continued Selling Pressure at Penny Level